Artigos

Search for articles

BJO Oncology - Placeholder

Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

ABSTRACT Objective: To evaluate pharmaceutical bioequivalence between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions. Material and Methods: An open label, monocentric, randomized, 2x2 crossover study in 32 healthy men under fasting conditions comparing two formulations of lenalidomide capsules. Analyte concentrations in human plasma were...
BJO Oncology - Placeholder

Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail

ABSTRACT Targeted and immunotherapy have revolutionized cancer treatment. They safely substitute for traditional chemotherapy in a significant and growing number of malignancies. In this article, we review the United States Food and Drug Administration (FDA) - approved targeted and immunotherapies, currently used in oncology and compare their safety and efficacy...